Limitations, agreements, and source contact

Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer · Source last updated 2021-04-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Early termination of the trial led to a small number of subjects analyzed.

point Of Contact

email

sk1375@cinj.rutgers.edu

organization

Rutgers Cancer Institute of New Jersey

phone

732-235-3986

title

Sung Kim, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice